Track Tyra Biosciences's current cash ($74M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current cash for TYRA is $74M as of June 2026. That compares with $98M in the prior-year period — down 25.0% year over year. Investors often review this figure alongside Tyra Biosciences's historical trend and sector peers before judging valuation or financial health.
Over the past year, TYRA's current cash moved from $98M to $74M — a 25.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tyra Biosciences's operating scale or balance-sheet position.
A current cash figure of $74M for TYRA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting TYRA's current cash ($74M), review year-over-year change from $98M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Tyra Biosciences's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.